Related references
Note: Only part of the references are listed.Safety and Efficacy of Low-Dose Prasugrel as Part of Triple Therapy With Aspirin and Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - From the TWMU-AF PCI Registry
Hisao Otsuki et al.
CIRCULATION JOURNAL (2019)
Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials
Samuel Seidu et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Ticagrelor improves blood viscosity-dependent microcirculatory flow in patients with lower extremity arterial disease: the Hema-kinesis clinical trial
Robert S. Rosenson et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions
Johannes Schmucker et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease
Liv Vernstrom et al.
THROMBOSIS RESEARCH (2018)
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
DIABETES CARE (2018)
Diabetes and antiplatelet therapy: from bench to bedside
Jose R. Rivas Rios et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2018)
A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia
Dorien Kiers et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
Katherine Kearney et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Association of MicroRNAs and YRNAs With Platelet Function
Dorothee Kaudewitz et al.
CIRCULATION RESEARCH (2016)
Global Burden of Thrombosis Epidemiologic Aspects
Aaron M. Wendelboe et al.
CIRCULATION RESEARCH (2016)
Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54
William A. E. Parker et al.
HEART (2016)
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel Results from a prospective, randomised, double-blind, placebo-controlled study
Francesco Franchi et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model
Mark R. Thomas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease
Christian Schulte et al.
PLOS ONE (2015)
Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3
Katharina Hess et al.
DIABETOLOGIA (2014)
Low-Dose Aspirin for Primary Prevention of Cardiovascular Everts in Japanese Patients 60 Years or Older Vuith Atherosclerotic Risk Factors A Randomized Clinical Trial
Yasuo Ikeda et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes
Rajiv R. Joshi et al.
PLATELETS (2014)
The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease
Sos Neergaard-Petersen et al.
THROMBOSIS AND HAEMOSTASIS (2014)
MicroRNAs Within the Continuum of Postgenomics Biomarker Discovery
Manuel Mayr et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Circulating MicroRNAs as Novel Biomarkers for Platelet Activation
Peter Willeit et al.
CIRCULATION RESEARCH (2013)
Fibrin Clot Structure and Platelet Aggregation in Patients with Aspirin Treatment Failure
Sos Neergaard-Petersen et al.
PLOS ONE (2013)
Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization The TRILOGY ACS Platelet Function Substudy
Paul A. Gurbel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Prospective Study on Circulating MicroRNAs and Risk of Myocardial Infarction
Anna Zampetaki et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Arterial thrombosis-insidious, unpredictable and deadly
Shaun P. Jackson
NATURE MEDICINE (2011)
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Anna Zampetaki et al.
CIRCULATION RESEARCH (2010)
Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation
Michael Pignone et al.
DIABETES CARE (2010)
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA
A. A. Kondkar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis
Jessica L. Mega et al.
LANCET (2010)
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
Lars Wallentin et al.
LANCET (2010)
Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System
R. A. Ajjan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans
Thea Morris et al.
JOURNAL OF IMMUNOLOGY (2009)
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38
Stephen D. Wiviott et al.
CIRCULATION (2008)
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial
Hisao Ogawa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
Jill Belch et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Heritability of clot formation, morphology, and lysis - The EuroCLOT study
Angela M. Carter et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inhibition of platelet aggregation by AZD6140, A reversible oral P2Y12 receptor antagonist, compared with clopidogral in patients with acute coronary syndrome
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation
John T. Brandt et al.
AMERICAN HEART JOURNAL (2007)
Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm
Hamad S. Al-Barjas et al.
ANGIOLOGY (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Amplified benefit of Clopidogrel versus aspirin in patients with diabetes mellitus
DL Bhatt et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)